Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium
Year: 2010
Type: article
Source: The Lancet Oncology
Institutions: Baylor College of Medicine, Azienda Ospedaliera San Camillo-Forlanini, Harvard University, Dana-Farber Cancer Institute, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Comprehensive Cancer Centers of Nevada
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2069624577
